For larger scale transfection of cell lines, e.g. suspension CHO or HEK293, in the LV Nucleocuvette® Cartridge format when working with the 4D-Nucleofector® LV Unit
Cryopreserved ampule of Normal Human Knee Articular Chondrocytes (NHAC-kn) containing ≥ 750,000 cells
PowerCHO® 2 CD, with HEPES, Pluronic® F-68, without L-Glutamine, Phenol red, hypoxanthine or thymidine, 10 L bag
RCGMTM SingleQuotsTM Kit (basal medium not included)
Cryopreserved Wistar Han Rat Hepatocytes, Suspension, are specifically pre tested for metabolic activity of general Phase I and Phase II metabolism in suspension. They are not suitable for applications requiring adherent cells. Each ampule contains > 5 million cells.
PowerCHO® 2, chemically defined Basal Powder, 500 L
-
Inducible Cas9 T Cells: An Innovative Platform for Allogeneic CAR-T Cell GenerationPoster on inducible Cas9 T Cells
-
Synthego_Lonza_Protocol_Genome Editing of Resting T cellsTechnical Protocol on Genome Editing of Resting T cells for associated White Paper "Genome Editing of Resting T cells"
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
-
PBMC Based T Cell Proliferation AssayProtocol instructions
-
Instructions for Use – TheraPEAK® T-VIVO® Cell Culture Medium for Gamma Delta (γδ) T CellsInstructions for how to culture gamma delta (γδ) T Cells using TheraPEAK® T-VIVO® Cell Culture Medium
-
Instructions for Use - Dendritic Cell (DC) and T Cell Assay from Matched PBMCsProtocol for DC and T Cell Assay from Matched PBMCs
-
Case Study – Improving the Expansion of Patients' T CellsIn this serum-free media case study, learn how selection of memory T cells can aid in streamlining CAR-T therapies.
-
Synthego-Lonza Genome Editing of Resting T cellsCase Study on Genome Editing of Resting T cells
-
cGMP Kit T Optimization Protocol - Nucleofector™ 1/2 Device SeriescGMP Cell Line Nucleofector Kit T
-
CAR-T Cells – Latest Advances and Outstanding Challenges